Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 26.76M P/E - EPS this Y -16.60% Ern Qtrly Grth -
Income -17.98M Forward P/E -1.09 EPS next Y 32.60% 50D Avg Chg 6.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 0.62 EPS next 5Y - 52W High Chg -58.00%
Recommedations 2.00 Quick Ratio 8.35 Shares Outstanding 10.17M 52W Low Chg 51.00%
Insider Own 30.03% ROA -36.68% Shares Float 7.11M Beta 1.35
Inst Own 6.72% ROE -54.54% Shares Shorted/Prior 4.97K/5.38K Price 2.63
Gross Margin - Profit Margin - Avg. Volume 26,996 Target Price 8.00
Oper. Margin - Earnings Date May 13 Volume 14,390 Change 2.33%
About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.

Cocrystal Pharma, Inc. News
03/28/24 Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
07:00 AM Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
03/05/24 Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap
02/20/24 COCP: Cocrystal Pharma provides updates on its clinical programs.
01/04/24 Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates
12/06/23 Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A
11/29/23 Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast
11/27/23 Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023
11/14/23 COCP: Cocrystal Pharma reports 3rd quarter financial results and provides updates on clinical trials.
11/13/23 Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
11/09/23 Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast
10/31/23 Cocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344
10/02/23 COCP: Cocrystal Pharma doses 1st subjects in the important CDI-988 clinical trial.
09/28/23 Cocrystal Pharma Doses First Subjects in Clinical Study of CDI-988 For Pandemic Norovirus and Coronavirus
09/05/23 Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
08/16/23 COCP: Cocrystal Pharma reports 2nd quarter 2023 financial results and provides updates on drug pipeline.
08/14/23 Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
08/08/23 Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead
05/31/23 Cocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988
05/17/23 COCP: Cocrystal Pharma reports 1st quarter 2023 financial results and provides updates on drug pipeline.
COCP Chatroom

User Image 711Coffee Posted - 1 day ago

$COCP wen pump

User Image SpiceTrade Posted - 2 days ago

$COCP Daily

User Image elon_musk22 Posted - 4 days ago

$COCP what a surprise mirisu you are so desperate how does it feel to be down and out and broke? momo was clearly right about you why would you change your name on the other account and open up a new burner and then like your dumb post

User Image elon_musk22 Posted - 4 days ago

$COCP I was right about you in a very short time you are broke and dumb and over a decade of posting and getting crushed. No I am not momo or any other of your wet dreams just someone who knows who the frauds are and you are one of them it must suck to lose all your money in the mkt

User Image momo2021 Posted - 4 days ago

$COCP beyond 12 months of cash and big time clinical data that rips mkt cap higher coming low float boomer otw perfect setup

User Image bulmar Posted - 5 days ago

$COCP So what happened to HCV? Why are we near lows Momo? How many times does the tree need shaking? Ask your boss please. Thanks 50x100x. If you think Momo is full of shit please confirm with the chart.

User Image momo2021 Posted - 6 days ago

$COCP The real big deal 2 monster clinical trials 1 in the UK the the other in AU but really 3 in progress (2 for 1) and a new phase 1 later this year is all the rocket fuel that is needed. Took a long time to get here but with positive results boomer. These trash poster leftovers are going to hate themselves so more than ever hahhahh Its all about the clinical data Serious company with a very conservative cash burn Most bears and bashers here is perfect setup

User Image momo2021 Posted - 6 days ago

$COCP broke and miserable bully boy or jai wei Joined ST 12/2013 and still never posted a winner ever and neither have any of his proxies all wiped out 🤣 I invite anybody to review his account and his pals the same pattern big mouth bashers and all losers on everything ps nice try with your new mirsu account changing the other to zack morris since 1/2016 to try to start over but its too late you have no money left 🤡 show

User Image bulmar Posted - 1 week ago

$COCP lol lol 50-100x lol lol.

User Image bulmar Posted - 1 week ago

$COCP This stock has so much Momo. He will go crazy and brag if we get back to two dollars. You’re gonna freak!

User Image mirisu Posted - 1 week ago

$COCP Well. Mister PhDms101 aka momo2021 aka aka aka some suspended accounts, predicted before 2nd r/s in 2021 a sooner price of $100+. Today, about 3 years later the reality is the following: Current share price is $1.55 after 2nd r/s. $1.55 is like $0.13 before 2nd r/s (1:12) and $0.0043 before 1st r/s (1:30). Mark aka momo2021 aka aka aka LOL jumps with joy when the price goes up a few cents and calls anyone who tells the truth a loser. BUT, he is the biggest broke loser, LOL. He never made a single successful trade. The $1'350.-- he paid in 2013 for each share he will never get back. Shake the tree Mark aka momo2021 aka aka aka :)

User Image momo2021 Posted - 1 week ago

$COCP liking his own posts as his first post on his own new account no wonder why you only lose money desperate and sad 🤡

User Image momo2021 Posted - 1 week ago

$COCP and mirsu lifetime ST basher is trying to rebrand himself with no money lololol can't make this up same account as @bulmar part of the same group of broke losers in the mkt 🤡

User Image momo2021 Posted - 1 week ago

$COCP just so everybody knows the real deal this poorly paid bash loser changed his name from miri su to _zack now Lolololo

User Image bulmar Posted - 1 week ago

$COCP What a surprise down today just same old Momo nonsense. Pump and dump chump. By the way AIM is kicking this turds trash. STFU.

User Image momo2021 Posted - 1 week ago

$COCP embarrassing 2700 share or $3k fat finger sell somebody now trying to cancel the trade too late lmfaooo

User Image momo2021 Posted - 1 week ago

$OPK $DJT $VERB $COCP who paid this crook? stock investor john = john jones = magic investor = resurrected magic = bulmar = joelogan etc etc wiped out and busted BLOCK and stay away from this 🤡 he has 5-10 burners he copies and pastes the same lies for years over 15k lies @Stock_Investor_John 6425 lies never a winner @Resurrected_Magic = 6325 lies never a winner @The_Original_Magic = 8210 lies removed by ST @bulmar = 6493 ideas no winners plus 5 others

User Image bulmar Posted - 1 week ago

$COCP Hey Momo that was Elon’s Venus fly trap..

User Image momo2021 Posted - 1 week ago

$OPK $WGS $COCP stock investor john = john jones = magic investor = resurrected magic = bulmar = joelogan etc etc common theme paid basher never one single winner ever busted

User Image Stock_Investor_John Posted - 1 week ago

$COCP 🤣😂🤣

User Image elon_musk22 Posted - 1 week ago

$COCP H5N1 bird flu play for sure soon stock can trigger just from this alone CC-42344

User Image momo2021 Posted - 1 week ago

$COCP resurrection pulling out his stock investor john burner account now lololol getting nervous on the upcoming bio boomer

User Image Stock_Investor_John Posted - 1 week ago

$COCP

User Image jacky1230 Posted - 1 week ago

$COCP bought more. Above 1.7 will buy more

User Image ChiefOG Posted - 2 weeks ago

$COCP 🔥

User Image Naty2806 Posted - 2 weeks ago

$OPGN $COCP today we Win, $SINT next week 🚀🚀🔥🤑

User Image momo2021 Posted - 2 weeks ago

$COCP boom boom bashers gonna freak soon

User Image Farms Posted - 2 weeks ago

$COCP Bird flu 👀

User Image momo2021 Posted - 2 weeks ago

$CADL $COCP what a monster winner ran over 10 in after hours another massive windfall in profits will add some more crystal to core as the same bashers keep scanning and wishing they weren't so paralyzed and broke and super jealous love it

User Image jacky1230 Posted - 2 weeks ago

$COCP until it’s over 1.7, or no buying

Analyst Ratings
HC Wainwright & Co. Buy Apr 4, 24
HC Wainwright & Co. Buy Mar 20, 24
HC Wainwright & Co. Buy Jan 3, 24
HC Wainwright & Co. Buy Dec 4, 23
HC Wainwright & Co. Buy Oct 4, 23
HC Wainwright & Co. Buy Aug 15, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy Jun 2, 23
HC Wainwright & Co. Buy May 24, 23